Blog
New Study Shows rTMS Offers Lasting Relief for Fibromyalgia Pain and Mood
A recent study has found that repetitive transcranial magnetic stimulation (rTMS), a non-invasive treatment that uses magnetic pulses, can significantly help people with fibromyalgia. This technique targets the prefrontal cortex, a part of the brain involved in pain and emotions. Participants who received the active rTMS showed noticeable improvements in pain, mood, and overall quality of life, with these benefits lasting for six months after treatment. The procedure was generally well-tolerated, with only minor and temporary side effects like headaches. This promising result suggests that rTMS could be a valuable option for managing fibromyalgia, though more research is needed to refine the approach and understand its long-term effects.
Read More
2024 CANMAT Guidelines: Comprehensive Approaches for Managing Depression in Adults
The updated 2024 guidelines from the Canadian Network for Mood and Anxiety Treatments (CANMAT) provide new recommendations for managing depression in adults. For mild depression, supervised exercise (30-40 minutes, 3-4 times a week for at least 9 weeks) is suggested as a first-line treatment, while it can also be added to other treatments for moderate depression. Light therapy is recommended as the primary treatment for seasonal (winter) depression. For severe depression with psychotic symptoms, a combination of antidepressant and antipsychotic medications is advised. First-line psychological treatments include cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), and behavioral activation (BA). There are 17 recommended antidepressants, including SSRIs and SNRIs, tailored to individual needs and depression severity. For difficult-to-treat depression, adjunctive medications like aripiprazole and brexpiprazole are useful. Maintaining antidepressant treatment for up to 12 months after remission is advised, with longer durations for those at high risk of relapse. St. John’s wort is recommended as a complementary treatment for mild to moderate depression. Emerging treatments, such as esketamine, ketamine infusions, and repetitive transcranial magnetic stimulation (rTMS), are considered for challenging cases. These guidelines emphasize personalized treatment plans to effectively manage depression based on the individual's specific needs and circumstances.
Read More
How Your Diet Can Help Manage Chronic Pain: What the Latest Research Reveals
Over the past decade, research has explored how different diets and supplements can help manage chronic pain by targeting inflammation, oxidative stress, and other underlying mechanisms. A review of existing studies found that while many articles discuss these dietary approaches, only a small portion are original research. Most studies have focused on chronic musculoskeletal pain, such as back pain, knee osteoarthritis, fibromyalgia, migraines, and neuropathic pain. Some effective dietary interventions include plant-based diets, low FODMAP diets, ketogenic diets, and omega-3 supplements, all of which may help reduce pain and improve quality of life. However, the research quality varies, and more rigorous studies are needed to draw definitive conclusions. Generally, combining diet with other treatments, such as medication and physical therapy, is recommended for better pain management. This review highlights the importance of individualized dietary guidance as part of a broader strategy to alleviate chronic pain.
Read More
New Migraine Prevention Therapy: CGRP Treatments Now a First-Line Option
The American Headache Society has recognized a new class of treatments called calcitonin gene-related peptide (CGRP)–targeting therapies as a top choice for preventing migraines. These treatments work by blocking a protein involved in triggering migraines, offering an effective alternative to older medications like beta-blockers and antidepressants, which can have tough side effects. CGRP therapies have been shown in studies to reduce the number of migraines and improve the quality of life for patients, including those who haven’t responded well to other treatments. This is a big step forward in migraine care, especially for those regularly dealing with these headaches.
Read More
Optimal Timing for Exercise Therapy in Knee Osteoarthritis: The Impact of Early Intervention on Pain and Function
The article highlights the effectiveness of exercise therapy for individuals with knee osteoarthritis, emphasizing that those who start exercising within the first year of symptoms experience the greatest benefits. Analyzing data from 1,769 participants, the study found that early intervention with exercise significantly reduces pain and improves physical function both in the short term (about 3 months) and long term (about 12 months). Those with symptoms for less than one year saw the most notable improvements compared to those with longer symptom durations. The findings suggest that initiating exercise therapy as soon as symptoms emerge can be crucial in managing and potentially slowing the progression of knee osteoarthritis.
Read More